FigureĀ 3.
Incidence of early cardiac toxicity according to donor type. (A) Cumulative incidence of early cardiac toxicity according to donor type. (B) Cumulative incidence of early cardiac toxicity according to GVHD prophylaxis in patients undergoing allo-HCTs from MSD and MUDs. (C) Cumulative incidence of early cardiac toxicity in patients undergoing allo-HCTs from MSD and MUDs according to the administration of TBI and PTCY-based prophylaxis. Notice that in plot E the y-axis has been limited to 0.5.